The Ovarian-Adnexal Reporting and Data System (O-RADS) for MRI provides a structured method for stratifying malignancy risk in adnexal masses. Endorsed by the American College of Radiology, it catego
READ MORE
Minimally invasive diagnostic procedures have become increasingly central in gynaecological oncology, particularly ultrasound-guided biopsies. These offer a reliable method to obtain adequate tissue...
READ MORE
As the healthcare sector continues to evolve in the digital age, a new dimension has emerged—one that links improved access to care with environmental responsibility. In Italy’s rural and mountainous
READ MORE
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a prevalent and pressing global health concern, driven largely by rising rates of obesity and metabolic syndr
READ MORE
Radiomics has emerged as a transformative approach in medical imaging, offering the potential to extract high-dimensional data from scans for enhanced disease characterisation and treatment
READ MORE
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality globally, accounting for the majority of lung cancer diagnoses. Immunotherapy targeting the PD-1/PD-L1 axis has emerge
READ MORE
Image quality assessment (IQA) is a foundational element in both clinical practice and medical image algorithm development. Yet, commonly used full reference (FR) IQA metrics such as Peak S
READ MORE
Contrast-enhanced ultrasound (CEUS) is a valuable tool for evaluating tumour ablation, offering real-time visualisation of lesion boundaries and microvascular perfusion. However, the need for contr
READ MORE
Accurate preoperative estimation of tumour size is vital in the management of breast cancer, particularly when the lesion presents as an architectural distortion (AD). These distortions, defined...
READ MORE
Extracting structured data from unstructured pathology reports remains a significant challenge in healthcare, particularly in oncology, where timely and accurate information is critical for
READ MORE
